BACKGROUND: The objective of this study was to evaluate the biomechanical characteristics and histologic remodeling of crosslinked (Peri-Guard, Permacol) and non-crosslinked (AlloDerm, Veritas) biologic meshes over a 12 month period using a porcine model of incisional hernia repair. STUDY DESIGN: Bilateral incisional hernias were created in 48 Yucatan minipigs and repaired after 21 days using an underlay technique. Samples were harvested at 1, 6, and 12 months and analyzed for biomechanical and histologic properties. The same biomechanical tests were conducted with de novo (time 0) meshes as well as samples of native abdominal wall. Statistical significance (p < 0.05) was determined using 1-way analysis of variance with a Fisher's least significant difference post-test. RESULTS: All repair sites demonstrated similar tensile strengths at 1, 6, and 12 months and no significant differences were observed between mesh materials (p > 0.05 in all cases). The strength of the native porcine abdominal wall was not augmented by the presence of the mesh at any of the time points, regardless of de novo tensile strength of the mesh. Histologically, non-crosslinked materials showed earlier cell infiltration (p < 0.01), extracellular matrix deposition (p < 0.02), scaffold degradation (p < 0.05), and neovascularization (p < 0.02) compared with crosslinked materials. However, by 12 months, crosslinked materials showed similar results compared with the non-crosslinked materials for many of the features evaluated. CONCLUSIONS: The tensile strengths of sites repaired with biologic mesh were not impacted by very high de novo tensile strength/stiffness or mesh-specific variables such as crosslinking. Although crosslinking distinguishes biologic meshes in the short-term for histologic features, such as cellular infiltration and neovascularization, many differences diminish during longer periods of time. Characteristics other than crosslinking, such as tissue type and processing conditions, are likely responsible for these differences.
BACKGROUND: The objective of this study was to evaluate the biomechanical characteristics and histologic remodeling of crosslinked (Peri-Guard, Permacol) and non-crosslinked (AlloDerm, Veritas) biologic meshes over a 12 month period using a porcine model of incisional hernia repair. STUDY DESIGN: Bilateral incisional hernias were created in 48 Yucatan minipigs and repaired after 21 days using an underlay technique. Samples were harvested at 1, 6, and 12 months and analyzed for biomechanical and histologic properties. The same biomechanical tests were conducted with de novo (time 0) meshes as well as samples of native abdominal wall. Statistical significance (p < 0.05) was determined using 1-way analysis of variance with a Fisher's least significant difference post-test. RESULTS: All repair sites demonstrated similar tensile strengths at 1, 6, and 12 months and no significant differences were observed between mesh materials (p > 0.05 in all cases). The strength of the native porcine abdominal wall was not augmented by the presence of the mesh at any of the time points, regardless of de novo tensile strength of the mesh. Histologically, non-crosslinked materials showed earlier cell infiltration (p < 0.01), extracellular matrix deposition (p < 0.02), scaffold degradation (p < 0.05), and neovascularization (p < 0.02) compared with crosslinked materials. However, by 12 months, crosslinked materials showed similar results compared with the non-crosslinked materials for many of the features evaluated. CONCLUSIONS: The tensile strengths of sites repaired with biologic mesh were not impacted by very high de novo tensile strength/stiffness or mesh-specific variables such as crosslinking. Although crosslinking distinguishes biologic meshes in the short-term for histologic features, such as cellular infiltration and neovascularization, many differences diminish during longer periods of time. Characteristics other than crosslinking, such as tissue type and processing conditions, are likely responsible for these differences.
Authors: R W Luijendijk; W C Hop; M P van den Tol; D C de Lange; M M Braaksma; J N IJzermans; R U Boelhouwer; B C de Vries; M K Salu; J C Wereldsma; C M Bruijninckx; J Jeekel Journal: N Engl J Med Date: 2000-08-10 Impact factor: 91.245
Authors: Maryellen Sandor; Hui Xu; Jerome Connor; Jared Lombardi; John R Harper; Ronald P Silverman; David J McQuillan Journal: Tissue Eng Part A Date: 2008-12 Impact factor: 3.845
Authors: Nadja K Burns; Mona V Jaffari; Carmen N Rios; Anshu B Mathur; Charles E Butler Journal: Plast Reconstr Surg Date: 2010-01 Impact factor: 4.730
Authors: Hui Xu; Hua Wan; Maryellen Sandor; Shijie Qi; Frank Ervin; John R Harper; Ronald P Silverman; David J McQuillan Journal: Tissue Eng Part A Date: 2008-12 Impact factor: 3.845
Authors: Meghan L Milburn; Luther H Holton; Thomas L Chung; Edward N Li; Grant V Bochicchio; Nelson H Goldberg; Ronald P Silverman Journal: Surg Infect (Larchmt) Date: 2008-08 Impact factor: 2.150
Authors: Bryan N Brown; Ricardo Londono; Stephen Tottey; Li Zhang; Kathryn A Kukla; Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak Journal: Acta Biomater Date: 2011-12-02 Impact factor: 8.947
Authors: Lindsey G Kahan; Spencer P Lake; Jared M McAllister; Wen Hui Tan; Jennifer Yu; Dominic Thompson; L Michael Brunt; Jeffrey A Blatnik Journal: Surg Endosc Date: 2017-07-21 Impact factor: 4.584
Authors: Matthew T Wolf; Yoram Vodovotz; Stephen Tottey; Bryan N Brown; Stephen F Badylak Journal: Tissue Eng Part C Methods Date: 2014-08-04 Impact factor: 3.056
Authors: Lisa E Carey; Christopher L Dearth; Scott A Johnson; Ricardo Londono; Christopher J Medberry; Kerry A Daly; Stephen F Badylak Journal: Biomaterials Date: 2014-07-03 Impact factor: 12.479